however, they are still not approved for use and available in the market
Being a leader in microneedling TDDS, their unique micro needle technology, DEN (Droplet Extension Needle), allows them to transfer drugs through a soluble micro needle. Raphas has FDA cGMP manufacturing validation for microneedle skin patches and has completed Phase 1 clinical trials
They improve insulin function, increase insulin sensitivity, lipid levels, and antioxidant activity
Let our team know how we can help with your goals
Take control of your health with professional care and effective treatment options
On the other hand, the actual GLP-1 microneedle patches with GLP-1 analogues like semaglutide are said to show results like reduced appetite and cravings, feelings of fullness and delayed gastric emptying 4